Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer
Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer
About this item
Full title
Author / Creator
Nozawa, Masahiro , Mukai, Hirofumi , Takahashi, Shunji , Uemura, Hiroji , Kosaka, Takeo , Onozawa, Yusuke , Miyazaki, Jun , Suzuki, Kazuhiro , Okihara, Koji , Arai, Yoichi , Kamba, Tomomi , Kato, Masashi , Nakai, Yasutomo , Furuse, Hiroshi , Kume, Haruki , Ide, Hisamitsu , Kitamura, Hiroshi , Yokomizo, Akira , Kimura, Takahiro , Tomita, Yoshihiko , Ohno, Keiji and Kakehi, Yoshiyuki
Publisher
Tokyo: Springer Japan
Journal title
Language
English
Formats
Publication information
Publisher
Tokyo: Springer Japan
Subjects
More information
Scope and Contents
Contents
Background
We previously reported the pharmacokinetic profile and preliminary tolerability of cabazitaxel in a phase I study in Japanese patients with metastatic castration-resistant prostate cancer (mCRPC). Here we report the final safety profile and anti-tumor activity of cabazitaxel in a larger population, including all patients enrolled in t...
Alternative Titles
Full title
Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer
Authors, Artists and Contributors
Author / Creator
Mukai, Hirofumi
Takahashi, Shunji
Uemura, Hiroji
Kosaka, Takeo
Onozawa, Yusuke
Miyazaki, Jun
Suzuki, Kazuhiro
Okihara, Koji
Arai, Yoichi
Kamba, Tomomi
Kato, Masashi
Nakai, Yasutomo
Furuse, Hiroshi
Kume, Haruki
Ide, Hisamitsu
Kitamura, Hiroshi
Yokomizo, Akira
Kimura, Takahiro
Tomita, Yoshihiko
Ohno, Keiji
Kakehi, Yoshiyuki
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1717969440
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1717969440
Other Identifiers
ISSN
1341-9625
E-ISSN
1437-7772
DOI
10.1007/s10147-015-0820-9
